TS
BIIB icon

Triglav Skladi’s Biogen BIIB Stock Holding History

Triglav Skladi’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28M Buy
12,428
+298
+2% +$54.9K 0.16% 80
2025
Q4 		$2.13M Sell
12,130
-6,000
-33% -$980K 0.13% 92
2025
Q3 		$2.54M Buy
18,130
+103
+0.6% +$13.9K 0.17% 70
2025
Q2 		$2.26M Hold
18,027
– – 0.16% 71
2025
Q1 		$2.47M Hold
18,027
– – 0.21% 69
2024
Q4 		$2.76M Buy
+18,027
New +$3.04M 0.22% 60

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Triglav Skladi's BIIB Position: Q1 2026 in Review

Triglav Skladi increased its Biogen (BIIB) stake by 2.5% in Q1 2026, buying an estimated $54.9K and bringing the position to 12,428 shares worth $2.28M. The position accounts for 0.16% of the portfolio, ranked #80.

Triglav Skladi first reported a position in BIIB in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.76M in Q4 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Triglav Skladi held 12,428 shares of Biogen worth $2.28M as of Q1 2026.
  • Triglav Skladi bought 298 Biogen shares in Q1 2026, an estimated $54.9K.
  • Biogen made up 0.16% of Triglav Skladi's portfolio in Q1 2026, its #80 holding.
  • Triglav Skladi first reported a position in Biogen in Q4 2024 and has held it in 6 quarters since.
  • Triglav Skladi's Biogen position peaked at $2.76M in Q4 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.